In Silico BCell Epitope Design of Zika Virus Vaccine Using “Zika Virus Isolate Zika Virus/H sapiensTc/Tha/2006/CVD_06020 Complete Genome”

Lisa Savitri, Syntia Tanu Juwita, Ester Lianawati Antoro, Ida Septika Wulansari, Datin An Nisa Sukmawati, João Gregório Freitas, Andre Mario Sequeira Alves Ornai

Abstract


ZIKV has been found in the cerebrospinal fluid (CSF) and brains of adults infected with viruses that manifest neurological disorders. ZIKV is a mosquito-borne single-stranded RNA virus, which belongs to the family Flaviviridae. The efforts of the scientific community have rapidly increased knowledge about this virus. However, understanding the complexities of ZIKV infection, transmission and pathogenesis remains an urgent challenge. Therefore, it is critical to study competent vectors and natural reservoirs for ZIKV, viral genetic diversity and flavivirus coinfection. Due to the great challenges to develop a ZIKV vaccine, it is still not possible to be immunized against ZIKV infection and related pathologies. The methods are nucleotide search for the Zika virus was carried out in silico, using the NCBI bioinformatics application by providing access to biomedical and genomic information. /H. sapiens-tc/THA/2006/CVD_06-020, the complete genome was then searched for FASTA, then prediction of vaccine epitope using the IEDB. The vaccine candidate peptides were analyzed for their antigenicity using VaxiJen. Proteins were classified by AllerTop to known allergenicity, then ToxinPred to predict and design toxic/non-toxic peptides. There are 30 peptide sequences are predicted to be a candidate of peptides B-cell epitope zika virus vaccine design using “zika virus isolate zika virus/H. sapiens-tc/THA/2006/CVD_06-020, complete genome”.


Keywords


Vaccine; Zika Virus; B-Cell Epitope; In Silico

Full Text:

PDF

References


Alves-Leon, S.V.; Lima, M.D.R.; Nunes, P.C.G.; Chimelli, L.M.C.; Rabelo, K.; Nogueira, R.M.R.; de Bruycker-Nogueira, F.; de Azeredo, E.L.; Bahia, P.R.; Rueda Lopes, F.C.; et al. (2019). Zika virus found in brain tissue of a multiple sclerosis patient undergoing an acute disseminated encephalomyelitis-like episode. Mult. Scler. (Houndmills Basingstoke Engl.), 2019, 25, 427–430.

Azevedo, R.S.; Araujo, M.T.; Martins Filho, A.J.; Oliveira, C.S.; Nunes, B.T.; Cruz, A.C.; Nascimento, A.G.; Medeiros, R.C.; Caldas, C.A.; Araujo, F.C.; et al. (2016). Zika virus epidemic in brazil. I. Fatal disease in adults: Clinical and laboratorial aspects. J. Clin. Virol. 2016, 85, 56–64.

Baud, D.; Gubler, D.J.; Schaub, B.; Lanteri, M.C.; Musso. (2017). D. An update on Zika virus infection Lancet 2017, 390, 2099–2109.

Barbi, L.; Coelho, A.V.C.; Alencar, L.C.A.; Crovella, S. (2018). Prevalence of guillain-barré syndrome among Zika virus infected cases: A systematic review and meta-analysis. Braz. J. Infect. Dis. 2018, 22, 137–141.

Bido-Medina, R.; Wirsich, J.; Rodríguez, M.; Oviedo, J.; Miches, I.; Bido, P.; Tusen, L.; Stoeter, P.; Sadaghiani, S. (2018). Impact of Zika virus on adult human brain structure and functional organization. Ann. Clin. Transl. Neurol. 2018, 5, 752–762.

Boyer, S.; Calvez, E.; Chouin-Carneiro, T.; Diallo, D.; Failloux, A.B. (2018). An overview of mosquito vectors of Zika virus. Microbes Infect. 2018, 20, 646-660.

Brasil, P.; Pereira, J.P., Jr.; Moreira, M.E.; Ribeiro Nogueira, R.M.; Damasceno, L.; Wakimoto, M.; Rabello, R.S.; Valderramos, S.G.; Halai, U.A.; Salles, T.S.; et al. (2016). Zika virus infection in pregnant women in rio de janeiro. N. Engl. J. Med.2016, 375, 2321–2334.

Brès, P. (1970). Recent data from serological surveys on the prevalence of arbovirus infections in africa, with special reference to yellow fever. Bull. World Health Organ. 1970, 43, 223–267.

Brito Ferreira, M.L.; Antunes de Brito, C.A.; Moreira, Á.J.P.; de Morais Machado,M.; Henriques Souza, A.; Cordeiro, M.T.; de Azevedo Marques, E.T.; Pena, L.J. (2017). Guillain-barré syndrome, acute disseminated encephalomyelitis and encephalitis associated with Zika virus infection in brazil: Detection of viral rna and isolation of virus during late infection. Am. J. Trop. Med. Hyg. 2017, 97, 1405–1409.

Carteaux, G.; Maquart, M.; Bedet, A.; Contou, D.; Brugières, P.; Fourati, S.; Cleret de Langavant, L.; de Broucker, T.; Brun-Buisson, C.; Leparc-Goffart, I.; et al. (2016). Zika virus associated with meningoencephalitis. N. Engl. J. Med. 2016, 374, 1595–1596.

Collins, N.D.; Widen, S.G.; Li, L.; Swetnam, D.M.; Shi, P.Y.; Tesh, R.B.; Sarathy, V.V. (2019). Inter-and intra-lineage genetic diversity of wild-type Zika viruses reveals both common and distinctive nucleotide variants and clusters of genomic diversity. Emerg. Microbes Infect. 2019, 8, 1126–1138.

Da Silva, I.R.F.; Frontera, J.A.; Bispo de Filippis, A.M.; Nascimento, O. (2017). Neurologic complications associated with the Zika virus in brazilian adults. JAMA Neurol. 2017, 74, 1190–1198.

Dick, G.W.; Kitchen, S.F.; Haddow, A.J. (1952). Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 1952, 46, 509–520.

Dudley, D.M.; Van Rompay, K.K.; Coffey, L.L.; Ardeshir, A.; Keesler, R.I.; Bliss-Moreau, E.; Grigsby, P.L.; Steinbach, R.J.; Hirsch, A.J.; MacAllister, R.P.; et al. (2018). Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates. Nat. Med. 2018, 24, 1104–1107.

Duffy, M.R.; Chen, T.H.; Hancock, W.T.; Powers, A.M.; Kool, J.L.; Lanciotti, R.S.; Pretrick, M.; Marfel, M.; Holzbauer, S.; Dubray, C.; et al. (2009). Zika virus outbreak on yap island, federated states of micronesia. N. Engl. J. Med. 2009, 360, 2536–2543.

Driggers, R.W.; Ho, C.Y.; Korhonen, E.M.; Kuivanen, S.; Jääskeläinen, A.J.; Smura, T.; Rosenberg, A.; Hill, D.A.; DeBiasi, R.L.; Vezina, G.; et al. (2016). Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N. Engl. J. Med. 2016, 374, 2142–2151.

Eligio-García, L.; Crisóstomo-Vázquez, M.D.P.; Caballero-García, M.L.; Soria-Guerrero, M.; Méndez-Galván, J.F.; López-Cancino, S.A.; Jiménez-Cardoso, E. (2019). Co-infection of dengue, Zika and chikungunya in a group of pregnant women from tuxtla gutiérrez, chiapas: Preliminary data. 2019. PLoS Negl. Trop. Dis. 2020, 14, e0008880.

Enfissi, A.; Codrington, J.; Roosblad, J.; Kazanji, M.; Rousset, D. (2016). Zika virus genome from the americas. Lancet 2016, 387, 227–228.

Gatherer, D.; Kohl, A. (2016). Zika virus: A previously slow pandemic spreads rapidly through the americas. J. Gen. Virol. 2016, 97, 269–273.

Gubler, D.J. (2011). Dengue, urbanization and globalization: The unholy trinity of the 21(st) century. Trop. Med. Health 2011, 39, 3–11.

Haddow, A.D.; Woodall, J.P. (2016). Distinguishing between Zika and spondweni viruses. Bull. World Health Organ. 2016, 94, 711.

Heinz, F.X.; Stiasny, K. (2017). The antigenic structure of Zika virus and its relation to other flaviviruses: Implications for infection and immunoprophylaxis. Microbiol. Mol. Biol. Rev. Mmbr 2017, 81, e00055-16.

Imperato, P.J. (2016). The convergence of a virus, mosquitoes, and human travel in globalizing the Zika epidemic. J. Community Health. 2016, 41, 674–679.

Koenig, K.L.; Majestic, C.; Burns, M.J. (2014). Ebola virus disease: Essential public health principles for clinicians. West. J. Emerg. Med. 2014, 15, 728–731.

Kuno, G.; Chang, G.J. (2007). Full-length sequencing and genomic characterization of bagaza, kedougou, and Zika viruses. Arch. Virol. 2007, 152, 687–696.

Kleber de Oliveira, W.; Cortez-Escalante, J.; De Oliveira, W.T.; do Carmo, G.M.; Henriques, C.M.; Coelho, G.E.; Araújo de França, G.V. (2016). Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy—Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep. 2016, 65, 242-247.

Lanciotti, R.S.; Lambert, A.J.; Holodniy, M.; Saavedra, S.; Signor Ldel, C. (2016). Phylogeny of Zika virus in western hemisphere, 2015. Emerg. Infect. Dis. 2016, 22, 933–935.

Leisher, S.H.; Balalian, A.A.; Reinebrant, H.; Shiau, S.; Flenady, V.; Kuhn, L.; Morse, S.S. (2020). Systematic review: Fetal death reporting and risk in Zika-affected pregnancies. Trop. Med. Int. Health 2020, 26, 133–145.

Lin, H.H.; Yip, B.S.; Huang, L.M.; Wu, S.C. (2018). Zika virus structural biology and progress in vaccine development. Biotechnol. Adv. 2018, 36, 47–53.

Macnamara, F.N. (1954). Zika virus: A report on three cases of human infection during an epidemic of jaundice in nigeria. Trans. R. Soc. Trop. Med. Hyg. 1954, 48, 139-145.

Martines, R.B.; Bhatnagar, J.; Keating, M.K.; Silva-Flannery, L.; Muehlenbachs, A.; Gary, J. Goldsmith, C.; Hale, G.; Ritter, J.; Rollin, D.; et al. (2016). Notes from the field: Evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep. 2016, 65, 159–160.

Mayer, S.V.; Tesh, R.B.; Vasilakis, N. (2017). The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and Zika fevers. Acta Trop. 2017, 166, 155 163.

McCoy, C.E.; Lotfipour, S.; Chakravarthy, B.; Schultz, C.; Barton, E. (2014). Emergency medical services public health implications and interim guidance for the ebola virus in the united states. West. J. Emerg. Med. 2014, 15, 723–727.

Mécharles, S.; Herrmann, C.; Poullain, P.; Tran, T.H.; Deschamps, N.; Mathon, G.; Landais, A.; Breurec, S.; Lannuzel, A. (2016). Acute myelitis due to Zika virus infection. Lancet 2016, 387, 1481.

Muñoz, L.S.; Barreras, P.; Pardo, C.A. (2016). Zika virus-associated neurological disease in the adult: Guillain-barré syndrome, encephalitis, and myelitis. Semin. Reprod. Med. 2016, 34, 273-279.

Musso, D. (2015). Zika virus transmission from french polynesia to brazil. Emerg. Infect. Dis. 2015, 21, 1887.

Nicastri, E.; Castilletti, C.; Balestra, P.; Galgani, S.; Ippolito, G. (2016). Zika virus infection in the central nervous system and female genital tract. Emerg. Infect. Dis. 2016, 22, 2228–2230.

Olson, J.G.; Ksiazek, T.G.; (1981). Suhandiman; Triwibowo. Zika virus, a cause of fever in central java, indonesia. Trans. R. Soc. Trop. Med. Hyg. 1981, 75, 389–393.

Parra, B.; Lizarazo, J.; Jiménez-Arango, J.A.; Zea-Vera, A.F.; González-Manrique, G.; Vargas, J.; Angarita, J.A.; Zuñiga, G.; Lopez-Gonzalez, R.; Beltran, C.L.; et al. (2016). Guillain-barré syndrome associated with Zika virus infection in colombia. N. Engl. J. Med. 2016, 375, 1513-1523.

Pierson, T.C.; Diamond, M.S. (2018). The emergence of Zika virus and its new clinical syndromes. Nature 2018, 560, 573–581.

Rathore, A.P.S.; St John, A.L. (2020). Cross-reactive immunity among flaviviruses. Front. Immunol. 2020, 11, 334.

Rezaldi, F., Taupiqurrohman O, Fadillah MF,Rochmat A, Humaedi A, Fadhilah F. (2021). Identifikasi Kandidat Vaksin COVID-19 Berbasis Peptida dari Glikoprotein Spike SARS CoV-2 untuk Ras Asia secara In Silico. Jurnal Biotek Mediasiana Indonesia 10 (1): 77-85. https://doi.org/10.22435/jbmi.v10i1.5031.

Rossati, A. (2017). Global warming and its health impact. Int. J. Occup. Environ. Med. 2017, 8, 7–20.

Safari, S.; Baratloo, A.; Rouhipour, A.; Ghelichkhani, P.; Yousefifard, M. (2015). Ebola hemorrhagic fever as a public health emergency of international concern: A review article. Emergency (Tehran Iran) 2015, 3, 3–7.

Savitri, L. (2021). Panduan Ringkas Desain Vaksin Berbasis Bioinformatika. Malang: Global Science.

Schwartzmann, P.V.; Ramalho, L.N.; Neder, L.; Vilar, F.C.; Ayub-Ferreira, S.M.; Romeiro, M.F.; Takayanagui, O.M.; Dos Santos, A.C.; Schmidt, A.; Figueiredo, L.T.; et al. (2017). Zika virus meningoencephalitis in an immunocompromised patient. Mayo Clin. Proc. 2017, 92, 460-466.

Shan, C.; Xie, X.; Shi, P.Y. (2018). Zika virus vaccine: Progress and challenges. Cell Host Microbe 2018, 24, 12–17.

Soares, C.N.; Brasil, P.; Carrera, R.M.; Sequeira, P.; de Filippis, A.B.; Borges, V.A.; Theophilo, F.; Ellul, M.A.; Solomon, T. (2016). Fatal encephalitis associated with Zika virus infection in an adult. J. Clin. Virol. 2016, 83, 63–65.

Terzian, A.C.B.; Schanoski, A.S.; Mota, M.T.O.; da Silva, R.A.; Estofolete, C.F.; Colombo, T.E.; Rahal, P.; Hanley, K.A.; Vasilakis, N.; Kalil, J.; et al. (2017). Viral load and cytokine response profile does not support antibody-dependent enhancement in dengue-primed Zika virus infected patients. Clin. Infect. Dis. 2017, 65, 1260–1265.

Vita, R., Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. (2015). The Immune Epitope Database (IEDB) 3.0. Nucleic Acids Res. 43: 405-412. https://doi.org/10.1093/nar/gku938.

WHO. (2017). WHO Situation Report. Zika Virus Microcephaly Guillain-Barré Syndrome. 2017.




DOI: https://doi.org/10.14421/biomedich.2023.122.525-531

Refbacks

  • There are currently no refbacks.




Copyright (c) 2023 Lisa Savitri, Syntia Tanu Juwita, Ester Lianawati Antoro, Ida Septika Wulansari, Datin An Nisa Sukmawati, João Gregório Freitas, Andre Mario Sequeira Alves Ornai



Biology, Medicine, & Natural Product Chemistry
ISSN 2089-6514 (paper) - ISSN 2540-9328 (online)
Published by Sunan Kalijaga State Islamic University & Society for Indonesian Biodiversity.

CC BY NC
This work is licensed under a CC BY-NC